{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T22:11:10Z","timestamp":1740175870017,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T00:00:00Z","timestamp":1551225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T00:00:00Z","timestamp":1551225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Spinal Cord Ser Cases"],"DOI":"10.1038\/s41394-019-0167-y","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T11:27:43Z","timestamp":1551266863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Is prophylaxis for osteoporosis indicated after acute spinal cord injury?"],"prefix":"10.1038","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6962-1583","authenticated-orcid":false,"given":"Yannis","family":"Dionyssiotis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,27]]},"reference":[{"key":"167_CR1","unstructured":"Garland DE, Adkins RH, Stewart CA. Bone Impairment and Spinal Cord Injury. In: Stone JH, Blouin M, editors. International Encyclopedia of Rehabilitation; 2013. http:\/\/cirrie.buffalo.edu\/encyclopedia\/en\/article\/108\/."},{"key":"167_CR2","first-page":"257","volume":"11","author":"Y Dionyssiotis","year":"2011","unstructured":"Dionyssiotis Y. Spinal cord injury-related bone impairment and fractures: an update on epidemiology and physiopathological mechanisms. J Musculoskelet Neuron Interact. 2011;11:257\u201365.","journal-title":"J Musculoskelet Neuron Interact"},{"key":"167_CR3","first-page":"63","volume-title":"Advances in osteoporosis, vol.1","author":"H Schiessl","year":"1998","unstructured":"Schiessl H, Ferretti JL, Tysarczyk-Niemeyer G, Willnecker J. The role of the muscles to the mechanical adaptation of bone. In: Lyritis GP, (ed). Advances in osteoporosis, vol.1. Athens: Hylonome Editions; 1998. p. 63\u201371."},{"key":"167_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/sj.sc.3101832","volume":"44","author":"L Maimoun","year":"2006","unstructured":"Maimoun L, Fattal C, Micallef JP, Peruchon E, Rabischong P. Bone loss in spinal cord-injured patients: from physiopathology to therapy. Spinal Cord. 2006;44:203\u201310.","journal-title":"Spinal Cord"},{"key":"167_CR5","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1007\/s00586-017-5114-7","volume":"27","author":"S Soleyman-Jahi","year":"2018","unstructured":"Soleyman-Jahi S, Yousefian A, Maheronnaghsh R, Shokraneh F, Zadegan SA, Soltani A, et al. Evidence-based prevention and treatment of osteoporosis after spinal cord injury: a systematic review. Eur Spine J. 2018;27:1798\u201314.","journal-title":"Eur Spine J"},{"key":"167_CR6","first-page":"674","volume":"33","author":"E Wilmet","year":"1995","unstructured":"Wilmet E, Ismail AA, Heilporn A, Welraeds D, Bergmann. Longitudinal study of the bone mineral content and of soft tissue composition after spinal cord injury. Paraplegia. 1995;33:674\u20137.","journal-title":"Paraplegia"},{"key":"167_CR7","first-page":"669","volume":"33","author":"D Uebelhart","year":"1995","unstructured":"Uebelhart D, Demiaux-Domenech B, Roth M, Chantraine A. Bone metabolism in spinal cord injured individuals and in others who have prolonged immobilisation. A review. Paraplegia. 1995;33:669\u201373.","journal-title":"Paraplegia"},{"key":"167_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/01952307.1992.11735870","volume":"15","author":"AN Elias","year":"1992","unstructured":"Elias AN, Gwinup G. Immobilization osteoporosis in paraplegia. J Am Paraplegia Soc. 1992;15:163\u201370.","journal-title":"J Am Paraplegia Soc"},{"key":"167_CR9","first-page":"84","volume":"2","author":"WA Bauman","year":"1997","unstructured":"Bauman WA, Garland DE, Schwartz E. Calcium metabolism and osteoporosis in individuals with spinal cord injury. Top Spinal Cord Inj Rehabil. 1997;2:84\u201396.","journal-title":"Top Spinal Cord Inj Rehabil"},{"key":"167_CR10","first-page":"139","volume":"61","author":"NE Naftchi","year":"1980","unstructured":"Naftchi NE, Viau AT, Sell GH, Lowman EW. Mineral metabolism in spinal cordinju ry. Arch Phys Med Rehabil. 1980;61:139\u201342.","journal-title":"Arch Phys Med Rehabil"},{"key":"167_CR11","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.pmrj.2014.08.948","volume":"7","author":"WA Bauman","year":"2015","unstructured":"Bauman WA, Cardozo CP. Osteoporosis in individuals with spinal cord injury. PMR. 2015;7:188\u2013201.","journal-title":"PMR"},{"key":"167_CR12","first-page":"316","volume":"74","author":"JM Meythaler","year":"1993","unstructured":"Meythaler JM, Tuel SM, Cross LL. Successful treatment of immobilization hypercalcemia using calcitonin and etidronate. Arch Phys Med Rehabil. 1993;74:316\u20139.","journal-title":"Arch Phys Med Rehabil"},{"key":"167_CR13","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1200\/JCO.2001.19.2.558","volume":"19","author":"P Major","year":"2001","unstructured":"Major P, Lortholary A, Hon J, et al. Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. J Clin Oncol. 2001;19:558\u201367.","journal-title":"J Clin Oncol"},{"key":"167_CR14","first-page":"41","volume":"67","author":"FM Maynard","year":"1986","unstructured":"Maynard FM. Immobilization hypercalcemia following spinal cord injury. Arch Phys Med Rehabil. 1986;67:41\u20134.","journal-title":"Arch Phys Med Rehabil"},{"key":"167_CR15","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1682\/JRRD.2004.05.0062","volume":"42","author":"WA Bauman","year":"2005","unstructured":"Bauman WA, Wecht JM, Kirshblum S, Spungen AM, Morrison N, Cirnigliaro C, et al. Effect of pamidronate administration on bone in patients with acute spinal cord injury. J Rehabil Res Dev. 2005;42:305\u201313.","journal-title":"J Rehabil Res Dev"},{"key":"167_CR16","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s11914-012-0117-0","volume":"10","author":"RA Battaglino","year":"2012","unstructured":"Battaglino RA, Lazzari AA, Garshick E, Morse LR. Spinal cord injury-induced osteoporosis: pathogenesis and emerging therapies. Curr Osteoporos Rep. 2012;10:278\u201385.","journal-title":"Curr Osteoporos Rep"},{"key":"167_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0003-9993(97)90032-0","volume":"78","author":"EG Pearson","year":"1997","unstructured":"Pearson EG, Nance PW, Leslie WD, Ludwig S. Cyclical etidronate: its effect on bone density in patients with acute spinal cord injury. Arch Phys Med Rehabil. 1997;78:269\u201372.","journal-title":"Arch Phys Med Rehabil"},{"key":"167_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0003-9993(99)90133-8","volume":"80","author":"PW Nance","year":"1999","unstructured":"Nance PW, Schryvers O, Leslie W, Ludwig S, Krahn J, Uebelhart D. Intravenous pamidronate attenuates bone density loss after acute spinal cord injury. Arch Phys Med Rehabil. 1999;80:243\u201351.","journal-title":"Arch Phys Med Rehabil"},{"key":"167_CR19","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1359\/JBMR.040313","volume":"19","author":"Y Zehnder","year":"2004","unstructured":"Zehnder Y, Risi S, Michel D, Knecht H, Perrelet R, Kraenzlin M, et al. Prevention of bone loss in paraplegics over 2 years with alendronate. J Bone Miner Res. 2004;19:1067\u201374.","journal-title":"J Bone Miner Res"},{"key":"167_CR20","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/jbmr.5650100116","volume":"10","author":"D Chappard","year":"1995","unstructured":"Chappard D, Minaire P, Privat C, Berard E, MendozaSarmiento J, Tournebise H, et al. Effects of tiludronate on bone loss in paraplegic patients. J Bone Miner Res. 1995;10:112\u201318.","journal-title":"J Bone Miner Res"},{"key":"167_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00198-010-1221-6","volume":"22","author":"JS Bubbear","year":"2011","unstructured":"Bubbear JS, Gall A, Middleton FR, Ferguson-Pell M, Swaminathan R, Keen RW. Early treatment with zoledronic acid prevents bone loss at the hip following acute spinal cord injury. Osteoporos Int. 2011;22:271\u20139.","journal-title":"Osteoporos Int"},{"key":"167_CR22","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s00223-007-9012-6","volume":"80","author":"J Shapiro","year":"2007","unstructured":"Shapiro J, Smith B, Beck T, Ballard P, Dapthary M, BrintzenhofeSzoc K, et al. Treatment with zoledronic acid ameliorates negative geometric changes in the proximal femur following acute spinal cord injury. Calcif Tissue Int. 2007;80:316\u201322.","journal-title":"Calcif Tissue Int"},{"key":"167_CR23","first-page":"833","volume":"8","author":"TJ Schnitzer","year":"2016","unstructured":"Schnitzer TJ, Kim K, Marks J, Yeasted R, Simonian N, Chen D. Zoledronic acid treatment after acute spinal cord injury: results of a randomized, placebo-controlled pilot. Trial PMR. 2016;8:833\u201343.","journal-title":"Trial PMR"},{"key":"167_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00198-015-3333-5","volume":"27","author":"L Gifre","year":"2016","unstructured":"Gifre L, Vidal J, Carrasco JL, Muxi A, Portell E, Monegal A, et al. Denosumab increases sublesional bone mass in osteoporotic individuals with recent spinal cord injury. Osteoporos Int. 2016;27:405\u201310.","journal-title":"Osteoporos Int"}],"container-title":["Spinal Cord Series and Cases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41394-019-0167-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41394-019-0167-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41394-019-0167-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T15:09:07Z","timestamp":1671203347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41394-019-0167-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,27]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["167"],"URL":"https:\/\/doi.org\/10.1038\/s41394-019-0167-y","relation":{},"ISSN":["2058-6124"],"issn-type":[{"type":"electronic","value":"2058-6124"}],"subject":[],"published":{"date-parts":[[2019,2,27]]},"assertion":[{"value":"30 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares no financial interest in relation to the work described.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"24"}}